CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 30 enrolled
Drug / intervention
Advair diskusdrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00974246
NCT00974246Phase 4Completed
CompareCT.gov

The Effect of Advair Diskus Treatment on Depression in Nursing Home Residents With COPD

Valley Medical Research·interventional·Posted Sep 10, 2009·Updated Dec 28, 2016

In Brief

A Phase 4 clinical trial evaluating Advair diskus for Chronic Obstructive Pulmonary Disease and Depression. Completed, enrolled 30 participants across 2 sites.

Detailed Summary

The purpose of this study is to assess the effect of treatment with Advair Diskus on depression using the Cornell depression scale in COPD patients in the nursing home.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsChronic Obstructive Pulmonary Disease, Depression
CountriesUnited States
Collaborators--

Timeline

Phase 4CompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedSep 10, 2009
Enrollment StartOct 1, 2009
Primary CompletionJul 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1.8 yearsPosted 16.8 years ago

Interventions

Advair diskusdrug

Advair diskus 50/250 1 inhalation bid for 16 weeks